Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: New Heart Imaging Techniques to Evaluate Possible Heart Disease [NA]
This update notes that the National Institute of Diabetes and Digestive and Kidney Diseases is recruiting for a study to evaluate new heart …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
An NHLBI-sponsored clinical trial in Washington, D.C. is developing a community-based behavioral weight loss intervention to improve cardiov…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
This clinical trial update describes an NHGRI-supported study investigating genetic factors related to obesity, diabetes, and heart disease …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Water Deprivation Protocol [NA]
This document reports the completion of a clinical trial conducted by the National Institute of Diabetes and Digestive and Kidney Diseases e…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Spinal Cord Injury Model Systems (SCIMS) - Education Module [NA]
An ongoing recruiting study sponsored by the University of Miami is developing an education module within the Spinal Cord Injury Model Syste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers [Phase 1]
Phase 1 clinical trial update to evaluate the safety of DWRX5003 and its relative bioavailability to DWC202502 and DWC202503 in healthy adul…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Intervention Based on the Dietary Guidelines for the Brazilian Population for the Treatment of Overweight and Obesity [NA]
A ClinicalTrials.gov update on a Brazil-based trial evaluating a dietary guidelines-based intervention to treat overweight and obesity; the …
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) [Phase 3]
A Phase 3 platform trial in pediatric participants with obesity or overweight is currently recruiting; no results are reported yet.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk [Phase 3]
A Phase 3 trial comparing daily oral orforglipron (LY3502970) to insulin glargine in adults with type 2 diabetes and obesity or overweight a…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effects of Concurrent Aerobic and Resistance Training After Bariatric Surgery in Women: RCT [NA]
A randomized controlled trial assessing the effects of a concurrent aerobic and resistance training program after bariatric surgery in women…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM [Phase 2]
Phase 2 study evaluating the efficacy and safety of once-weekly MET097 in adults with obesity or overweight and Type 2 Diabetes Mellitus has…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 [Phase 3]
Phase 3 master protocol study evaluating Orforglipron (LY3502970) in participants with hypertension and obesity; study is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight [Phase 3]
Phase 3 study evaluating Eloralintide (LY3841136) for obstructive sleep apnea in adults with obesity or overweight; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight [Phase 3]
A Phase 3 trial assessing Mirikizumab and Tirzepatide in adults with moderately to severely active Crohn's disease and obesity or overweight…
-
CLINICAL_TRIALS withdrawal · 2026-04-17Clinical Trial Update: Tailoring Obesity Treatment Trial [Phase 2, Phase 3]
A Phase 2/3 trial titled 'Tailoring Obesity Treatment' sponsored by Esbjerg Hospital – University Hospital of Southern Denmark has been with…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes [Phase 1]
Phase 1 study of LY4086940 in healthy volunteers and participants with overweight or obesity, with or without type 2 diabetes, currently rec…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: RESCUE: Discontinuation of GLP-1
Clinical trial update for obesity (RESCUE) notes discontinuation of a GLP-1 therapy; the trial status remains recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK) [Phase 4]
Phase 4 clinical trial evaluating tirzepatide versus standard of care in adults with obesity without diabetes. The SURMOUNT-REAL UK study is…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effect of Tai Chi and Multimodal Exercise in Overweight and Obese Women [NA]
A clinical trial from Pamukkale University assessing Tai Chi and multimodal exercise in overweight and obese women has completed.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain [Phase 3]
Retatrutide (LY3437943) is being studied in a Phase 3 trial for obesity or overweight with chronic low back pain, and the study is currently…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2 [Phase 3]
Phase 3 master protocol trial of Orforglipron (LY3502970) in participants with hypertension and obesity is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Timing Exercise Training as Strategy to Improve Insulin Sensitivity and Substrate Metabolism in Men and Woman With Pre-diabetes [NA]
This clinical trial update reports the completion of a study examining whether timing of exercise training improves insulin sensitivity and …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study [Phase 3]
A Phase 3b trial is evaluating concurrent administration of mirikizumab with tirzepatide in adults with moderately to severely active ulcera…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of tirzepatide after initiating ixekizumab in adults with moderate-to-severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector [Phase 1]
Phase 1 study by Boehringer Ingelheim comparing two formulations of Survodutide administered via different delivery methods in healthy indiv…